Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Statement

8 Jan 2014 07:00

RNS Number : 1239X
Persimmon PLC
08 January 2014
 



TRADING UPDATE - 8 JANUARY 2014

 

 

Persimmon plc announces the following update ahead of its Final Results for the year ended 31 December 2013, which will be released on 25 February 2014.

 

The Group has had a strong finish to the year. As indicated in our Interim Management Statement on 6 November 2013 we responded swiftly to the significant increase in weekly sales rates by substantially increasing our construction activity across the country. We are pleased to report that the Group has increased the volume of new house sales delivered to 11,528 for the year, 16% ahead of the previous year. Our robust build disciplines enabled the Group to legally complete 6,506 new homes in the second half of the year which is an increase of 30% over the first half of 2013. Second half sales volumes are 25% ahead of the prior year (2012 : 5,191).

 

The average selling price for our 2013 legal completions was c.£180,900, an increase of 4% over 2012 (£173,823). This increase is due to the change in mix of sales of our traditional family housing across the UK year on year. Full year revenues of £2.1bn represents an increase of 21% over the prior year.

 

This growth in revenues and the anticipated further improvement in operating margins will enable us to deliver strong underlying pre tax profit growth for the year ended 31 December 2013 demonstrating further progress with the delivery of the long term strategic plan announced in February 2012.

 

We acquired c.17,600 plots of new land during 2013, representing a replacement rate of 153% of current consumption, and once again demonstrating our appetite to invest in further growth. The land market in our regional operating areas continues to offer attractive investment opportunities with c.10,100 plots acquired in the second half of 2013.

 

Of the c.17,600 plots acquired in 2013, over 5,500 plots were converted from our strategic land bank. The superior returns from these strategic land parcels will support Group profitability and cashflows as they are developed over future years.

 

In line with expectations, we successfully opened the 85 sites identified for the second six months of 2013 and enter the new year with 390 active sites across the UK. We anticipate opening a further 90 new sites in the first half of 2014 and expect to see stable total active site numbers through the first half of 2014.

 

We continued to experience robust private sales rates through to the year end and despite the substantial increase in legal completions achieved in the second half of 2013, the value of our total forward sales at 31 December 2013 was 41% ahead of the prior year at c.£908m (2012 : £645m). The number of reserved and exchanged private sales carried forward into 2014, at over 3,000 new homes, is c.55% stronger than at the same time last year. A similar number of affordable homes have been pre-sold reflecting a c.9% increase on the prior year. This strong forward sales position provides a solid platform for further sales growth in 2014.

 

Our cash holdings have continued to strengthen despite our strong investment in land and work in progress through the second half of the year. We held cash balances of c.£204m at 31 December 2013 (2012 : £201m).

 

We will give a further update on our assessment of the housing market over the early weeks of 2014 when we announce our results for the year ended 31 December 2013 on Tuesday 25 February 2014.

 

Please Note

There will be a call for analysts at 9.00 a.m. GMT today. Please use the dial-in details below:

 

Telephone number : +44 (0)20 3003 2666

Conference code : Persimmon

 

An audiocast of the call will be available on www.corporate.persimmonhomes.comfrom this afternoon.

 

 

For further information please contact:

 

Jeff Fairburn, Group Chief Executive Simon Rigby

Mike Killoran, Group Finance Director Kevin Smith

Persimmon plc Lindsay Noton

Tel: +44 (0) 1904 642199 Citigate Dewe Rogerson

Tel: +44 (0) 20 7638 9571

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRMRTMBMMBTI
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.